Adaptive Biotechnologies Corp reports results for the quarter ended in March - Earnings Summary

Adaptive Biotechnologies

05/05/2022 18:13

* Adaptive Biotechnologies Corp  ADPT.OQ  reported a
quarterly
adjusted loss of 44 cents​​ per share for the quarter ended in
March. The mean expectation of seven analysts for the quarter
was for a loss of 45 cents per share.
    * Revenue rose 0.5% to $38.62 million from a year ago; 
analysts
expected $37.71 million. 
    * Adaptive Biotechnologies Corp's reported EPS for the
quarter was
a loss of 44 cents​.
    * The mean earnings estimate of analysts had risen by
about 1.7%
in the last three months.​ 
    * In the last 30 days one analyst negatively revised an
earnings
estimate 
    * Adaptive Biotechnologies Corp shares had fallen by 33.4%
this
quarter and lost 67.0% so far this year.
    * The company reported a quarterly loss of $62.74 million.
    * Wall Street's median 12-month price target for Adaptive
Biotechnologies Corp is $26.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 5 at 05:12 p.m.  ​All
figures in US dollars unless otherwise stated